Author Page for Yan Zhang

Actions:

View:
Selected
Original List
All Versions Hide All Versions
All Abstracts Hide All Abstracts

(Rank)

Deferoxamine Mitigates Neuronal Loss Following Spinal Cord Injury Via Ferroptosis Inhibition and Nrf2/Ho-1 Pathway Activation

Downloads 112 (645,052)

Deferoxamine Mitigates Neuronal Loss Following Spinal Cord Injury Via Ferroptosis Inhibition and Nrf2/Ho-1 Pathway Activation

Number of pages: 23 Posted: 08 Aug 2024

Yan Zhang, Ziqian Ma, Xinwei Zhang, Tao Liu, Peng Zhao, Yanjun Zhang, Bo Li, Zhijian Wei, Liang Liu and Xueming Chen

Capital Medical University, Capital Medical University, Capital Medical University, Capital Medical University, Capital Medical University, Capital Medical University, Capital Medical University, Shandong University, Capital Medical University and Capital Medical University

Downloads 59 (996,491)

Abstract:

Deferoxamine Mitigates Neuronal Loss Following Spinal Cord Injury Via Ferroptosis Inhibition and Nrf2/Ho-1 Pathway Activation

Number of pages: 22 Posted: 06 May 2024

Yan Zhang, Ziqian Ma, Xinwei Zhang, Tao Liu, Peng Zhao, Yanjun Zhang, Bo Li, Zhijian Wei, Liang Liu and Xueming Chen

Capital Medical University, Capital Medical University, affiliation not provided to SSRN, Capital Medical University, Capital Medical University, Capital Medical University, Capital Medical University, Shandong University, Capital Medical University and Capital Medical University

Downloads 53 (1,072,374)

Yan Zhang

Capital Medical University

1

112

0

Scholarly Papers (1)

Deferoxamine Mitigates Neuronal Loss Following Spinal Cord Injury Via Ferroptosis Inhibition and Nrf2/Ho-1 Pathway Activation

Deferoxamine Mitigates Neuronal Loss Following Spinal Cord Injury Via Ferroptosis Inhibition and Nrf2/Ho-1 Pathway Activation

Abstract:

Deferoxamine Mitigates Neuronal Loss Following Spinal Cord Injury Via Ferroptosis Inhibition and Nrf2/Ho-1 Pathway Activation

Abstract: